Surveillance protocol kidney transplant biopsies: Their evolving role in clinical practice

American Journal of Transplantation

Volumn 11, Issue 8, 2011, Pages 1570-1575

  Henderson, L K ^a   Nankivell, B J ^a   Chapman, J R ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Calcineurin nephrotoxicity; protocol biopsy; subclinical rejection; surveillance

Indexed keywords

CALCINEURIN INHIBITOR; STEROID;

CLINICAL PRACTICE; CLINICAL PROTOCOL; COST BENEFIT ANALYSIS; DRUG WITHDRAWAL; FIBROSING ALVEOLITIS; GRAFT REJECTION; HIGH RISK PATIENT; HISTOLOGY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INDIVIDUALIZATION; KIDNEY ALLOGRAFT; KIDNEY BIOPSY; KIDNEY DISEASE; KIDNEY TRANSPLANTATION; NEPHROTOXICITY; PRIORITY JOURNAL; RECURRENT DISEASE; REVIEW; SAFETY; SUBCLINICAL REJECTION;

BIOPSY; HUMANS; KIDNEY DISEASES; KIDNEY TRANSPLANTATION; POPULATION SURVEILLANCE;

EID: 79961051172     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2011.03677.x     Document Type: Review

References (53)

1. Burdick JF, McGraw D, Bender W, et al,. Renal allograft infiltrate in the absence of rejection. Transplant Proc 1984; 16: 1580-1582. (Pubitemid 15189244)
2. Kurtkoti J, Sakhuja V, Sud K, et al,. The utility of 1- and 3-month protocol biopsies on renal allograft function: A randomized controlled study. Am J Transplant 2008; 8: 317-323.
3. Choi BS, Shin MJ, Shin SJ, et al,. Clinical significance of an early protocol biopsy in living-donor renal transplantation: Ten-year experience at a single center. Am J Transplant 2005; 5: 1354-1360. (Pubitemid 40839425)
4. Kee TY, Chapman JR, O'Connell PJ, et al,. Treatment of subclinical rejection diagnosed by protocol biopsy of kidney transplants. Transplantation 2006; 82: 36-42. (Pubitemid 44296975)
5. Heilman RL, Devarapalli Y, Chakkera HA, et al,. Impact of subclinical inflammation on the development of interstitial fibrosis and tubular atrophy in kidney transplant recipients. Am J Transplant 2010; 10: 563-570.
6. Rush DN, Henry SF, Jeffery JR, et al,. Histological findings in early routine biopsies of stable renal allograft recipients. Transplantation 1994; 57: 208-211. (Pubitemid 24048586)
7. Rush D, Nickerson P, Gough J, et al,. Beneficial effects of treatment of early subclinical rejection: A randomized study. J Am Soc Nephrol 1998; 9: 2129-2134. (Pubitemid 28482163)
8. Nankivell BJ, Borrows RJ, Fung CL, et al,. The natural history of chronic allograft nephropathy. N Engl J Med 2003; 349: 2326-2333. (Pubitemid 37509740)
9. Legendre C, Thervet E, Skhiri H, et al,. Histologic features of chronic allograft nephropathy revealed by protocol biopsies in kidney transplant recipients. Transplantation 1998; 65: 1506-1509. (Pubitemid 28285256)
10. Cosio FG, Grande JP, Wadei H, et al,. Predicting subsequent decline in kidney allograft function from early surveillance biopsies. Am J Transplant 2005; 5: 2464-2472.
11. Shishido S, Asanuma H, Nakai H, et al,. The impact of repeated subclinical acute rejection on the progression of chronic allograft nephropathy. J Am Soc Nephrol 2003; 14: 1046-1052. (Pubitemid 36359287)
12. Moreso F, Ibernon M, Goma M, et al,. Subclinical rejection associated with chronic allograft nephropathy in protocol biopsies as a risk factor for late graft loss. Am J Transplant 2006; 6: 747-752. (Pubitemid 43345012)
13. Rush D, Arlen D, Boucher A, et al,. Lack of benefit of early protocol biopsies in renal transplant patients receiving TAC and MMF: Arandomized study. Am J Transplant 2007; 7: 2538-2545. (Pubitemid 47561621)
14. Mengel M, Gwinner W, Schwarz A, et al,. Infiltrates in protocol biopsies from renal allografts. Am J Transplant 2007; 7: 356-365. (Pubitemid 46096328)
15. Seikku P, Krogerus L, Jalanko H, et al,. Better renal function with enhanced immunosuppression and protocol biopsies after kidney transplantation in children. Pediatr Transplant 2005; 9: 754-762. (Pubitemid 41680711)
16. Nemeth D, Ovens J, Opelz G, et al,. Does borderline kidney allograft rejection always require treatment? Transplantation 2010; 90: 427-432.
17. Anil Kumar MS, Irfan Saeed M, Ranganna K, et al,. Comparison of four different immunosuppression protocols without long-term steroid therapy in kidney recipients monitored by surveillance biopsy: Five-year outcomes. Transpl Immunol 2008; 20: 32-42.
18. Roberts IS, Stratopoulos C, Zilvetti M, et al,. Impact of immunosuppression on the incidence of early subclinical renal allograft rejection: Implications for protocol biopsy policy. Transpl Int 2009; 22: 831-836.
19. Scholten EM, Rowshani AT, Cremers S, et al,. Untreated rejection in 6-month protocol biopsies is not associated with fibrosis in serial biopsies or with loss of graft function. J Am Soc Nephrol 2006; 17: 2622-2632. (Pubitemid 44300980)
20. Gloor JM, DeGoey SR, Pineda AA, et al,. Overcoming a positive crossmatch in living-donor kidney transplantation. Am J Transplant 2003; 3: 1017-1023. (Pubitemid 36917550)
21. Kraus ES, Parekh RS, Oberai P, et al,. Subclinical rejection in stable positive crossmatch kidney transplant patients: Incidence and correlations. Am J Transplant 2009; 9: 1826-1834.
22. Setoguchi K, Ishida H, Shimmura H, et al,. Analysis of renal transplant protocol biopsies in ABO-incompatible kidney transplantation. Am J Transplant 2008; 8: 86-94.
23. Cardarelli F, Pascual M, Tolkoff-Rubin N, et al,. Prevalence and significance of anti-HLA and donor-specific antibodies long-term after renal transplantation. Transpl Int 2005; 18: 532-540. (Pubitemid 41726855)
24. Panigrahi A, Deka R, Bhowmik D, et al,. Immunological monitoring of posttransplant allograft sensitization following living related donor renal transplantation. Transplant Proc 2004; 36: 1336-1339. (Pubitemid 38902971)
25. Anglicheau D, Loupy A, Lefaucheur C, et al,. A simple clinico-histopathological composite scoring system is highly predictive of graft outcomes in marginal donors. Am J Transplant 2008; 8: 2325-2334.
26. Munivenkatappa RB, Schweitzer EJ, Papadimitriou JC, et al,. The Maryland aggregate pathology index: A deceased donor kidney biopsy scoring system for predicting graft failure. Am J Transplant 2008; 8: 2316-2324.
27. Shapiro R, Randhawa P, Jordan ML, et al,. An analysis of early renal transplant protocol biopsies-The high incidence of subclinical tubulitis. Am J Transplant 2001; 1: 47-50. (Pubitemid 33681680)
28. Jain S, Curwood V, White SA, et al,. Sub-clinical acute rejection detected using protocol biopsies in patients with delayed graft function. Transpl Int 2000; 13 (Suppl 1): S52-S55.
29. Lehtonen SR, Taskinen EI, Isoniemi HM,. Histological alterations in implant and one-year protocol biopsy specimens of renal allografts. Transplantation 2001; 72: 1138-1144. (Pubitemid 32924090)
30. Schwarz A, Mengel M, Gwinner W, et al,. Risk factors for chronic allograft nephropathy after renal transplantation: A protocol biopsy study. Kidney Int 2005; 67: 341-348. (Pubitemid 40019257)
31. Seron D, Moreso F,. Protocol biopsies and risk factors associated with chronic allograft nephropathy. Transplant Proc 2002; 34: 331-332. (Pubitemid 34311695)
32. Oberbauer R, Segoloni G, Campistol JM, et al,. Early cyclosporine withdrawal from a sirolimus-based regimen results in better renal allograft survival and renal function at 48 months after transplantation. Transpl Int 2005; 18: 22-28. (Pubitemid 41742941)
33. Nankivell BJ, Wavamunno MD, Borrows RJ, et al,. Mycophenolate mofetil is associated with altered expression of chronic renal transplant histology. Am J Transplant 2007; 7: 366-376. (Pubitemid 46096329)
34. Nankivell BJ, Borrows RJ, Fung CL, et al,. Calcineurin inhibitor nephrotoxicity: Longitudinal assessment by protocol histology. Transplantation 2004; 78: 557-565. (Pubitemid 39097102)
35. Flechner SM, Kurian SM, Solez K, et al,. De novo kidney transplantation without use of calcineurin inhibitors preserves renal structure and function at two years. Am J Transplant 2004; 4: 1776-1785. (Pubitemid 39434437)
36. Vincenti F, Larsen C, Durrbach A, et al,. Costimulation blockade with belatacept in renal transplantation. N Engl J Med 2005; 353: 770-781. (Pubitemid 41215486)
37. Durrbach A, Pestana JM, Pearson T, et al,. A phase III study of belatacept versus cyclosporine in kidney transplants from extended criteria donors (BENEFIT-EXT study). Am J Transplant 2010; 10: 547-557.
38. Naesens M, Lerut E, Damme BV, et al,. Tacrolimus exposure and evolution of renal allograft histology in the first year after transplantation. Am J Transplant 2007; 7: 2114-2123. (Pubitemid 47247039)
39. Stegall MD, Park WD, Larson TS, et al,. The histology of solitary renal allografts at 1 and 5 years after transplantation. Am J Transplant 2011; 11: 698-707.
40. Hirsch HH,. Polyomavirus BK nephropathy: A (re-)emerging complication in renal transplantation. Am J Transplant 2002; 2: 25-30. (Pubitemid 36306804)
41. Randhawa P, Ho A, Shapiro R, et al,. Correlates of quantitative measurement of BK polyomavirus (BKV) DNA with clinical course of BKV infection in renal transplant patients. J Clin Microbiol 2004; 42: 1176-1180. (Pubitemid 38332843)
42. Buehrig CK, Lager DJ, Stegall MD, et al,. Influence of surveillance renal allograft biopsy on diagnosis and prognosis of polyomavirus-associated nephropathy. Kidney Int 2003; 64: 665-673. (Pubitemid 36871940)
43. Wavamunno MD, O'Connell PJ, Vitalone M, et al,. Transplant glomerulopathy: Ultrastructural abnormalities occur early in longitudinal analysis of protocol biopsies. Am J Transplant 2007; 7: 2757-2768. (Pubitemid 350045771)
44. Gloor JM, Sethi S, Stegall MD, et al,. Transplant glomerulopathy: Subclinical incidence and association with alloantibody. Am J Transplant 2007; 7: 2124-2132. (Pubitemid 47247042)
45. Gloor JM, Cosio FG, Rea DJ, et al,. Histologic findings one year after positive crossmatch or ABO blood group incompatible living donor kidney transplantation. Am J Transplant 2006; 6: 1841-1847. (Pubitemid 44024955)
46. Schwarz A, Krause PH, Offermann G, et al,. Impact of de novo membranous glomerulonephritis on the clinical course after kidney transplantation. Transplantation 1994; 58: 650-654. (Pubitemid 24317761)
47. Norby GE, Strom EH, Midtvedt K, et al,. Recurrent lupus nephritis after kidney transplantation: A surveillance biopsy study. Ann Rheum Dis 2010; 69: 1484-1487.
48. Dabade TS, Grande JP, Norby SM, et al,. Recurrent idiopathic membranous nephropathy after kidney transplantation: A surveillance biopsy study. Am J Transplant 2008; 8: 1318-1322. (Pubitemid 351763689)
49. Furness PN, Philpott CM, Chorbadjian MT, et al,. Protocol biopsy of the stable renal transplant: A multicenter study of methods and complication rates. Transplantation 2003; 76: 969-973. (Pubitemid 37186029)
50. Schwarz A, Gwinner W, Hiss M, et al,. Safety and adequacy of renal transplant protocol biopsies. Am J Transplant 2005; 5: 1992-1996. (Pubitemid 41039876)
51. Seron D, Moreso F,. Protocol biopsies in renal transplantation: Prognostic value of structural monitoring. Kidney Int 2007; 72: 690-697. (Pubitemid 47373786)
52. Farris AB, Adams CD, Brousaides N, et al,. Morphometric and visual evaluation of fibrosis in renal biopsies. J Am Soc Nephrol 2011; 22: 176-186.
53. Schaub S, Mayr M, Honger G, et al,. Detection of subclinical tubular injury after renal transplantation: Comparison of urine protein analysis with allograft histopathology. Transplantation 2007; 84: 104-112. (Pubitemid 47094649)